Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for ...

Australia's Therapeutic Goods Administration has approved the use of a new and first treatment for geographic atrophy - a disease which causes severe ...

Pharmaceuticals announced that the Therapeutic Goods Administration, TGA, has approved SYFOVRE or pegcetacoplan, for the ...

WALTHAM, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for the every-other-month ...

Subscribe to the Wake Up, cleveland.com’s free morning newsletter, delivered to your inbox weekdays at 5:30 a.m. President Donald Trump began his second term with sweeping executive actions to deter ...

I’m Caring for a Man With a Progressive Illness. But I’m Not Ready to Give Up Sex.

Dear: I would like to find out if my 72-year-old mother is eligible for food stamps or any other type of assistance program.

Study from Case Western Reserve University and VA Northeast Ohio Healthcare System examines genetic risk profiles across ...